Billions on Showtime, Episode 12: The Conversation

source: Showtime
source: Showtime

May I just say I will miss Sunday nights so much? Here’s my typical Billions Sunday: Watch at 10pm and live tweet. Take notes. Watch for a second time at 11pm. Take more notes. Sit down at midnight and start to write. Go to bed as the sun rises. It sounds crazy, doesn’t it? Sitting down to write for hours as if the world is waiting for my recap to be published… But it is not that. It is the thrill. I just LOVE the ride. Billions is such a pleasant puzzle to think about and write on. Standing Ovation for all brilliant minds behind and in front of the camera for the last 12 weeks! And special thanks go to my husband for bearing with me for the last couple of months and letting me sleep until noon on Mondays.

Continue reading “Billions on Showtime, Episode 12: The Conversation”

Catching up with Axe & Wags on
Billions Season 1 Finale Set

source: Showtime
source: Showtime

Time flies! Can you believe it’s our last rendezvous with Axe & Co, fortunately only for a while, in a couple of days? I just can’t.

Bad news: We will have serious withdrawals.

Good news: We can always go back to Billions Season 1 and watch it. Again. And again. And again.

Better news: They are starting to shoot Season 2 later this year.

Best news: We will have Billions Season 2 coming our way sometime next year.

So the season may be coming to an end, but we still have so much to say about it. For starters, we are currently working on a FUN Best of Billions post that we will publish as soon as the season is over. One of the categories we have to take our pick in is Best Chemistry. And I just can’t help reveal my vote here today: In my humble opinion, Axe and Wags have the most brilliant chemistry on screen and, believe me, off screen, too!

Continue reading “Catching up with Axe & Wags on Billions Season 1 Finale Set”

Billions ep 11 : Magical Thinking

Master of reading the charts and anticipating risk, master of seeing the long shot and taking the short road to get there, Difference Maker Bobby Axelrod has had a slip in judgement. He hasn’t seen what every other manager and analyst, “to a man”, has seen, and by refusing to budge in the face of the majority opinion, he proceeds to lose. And lose big. Axe Capital is on the brink of losing upwards of $800 million simply due to Bobby’s stubborn and ill-conceived refusal to see the numbers he’s always been able to see. But was it a refusal to see the big picture or an incapacity? Is Axe losing his wizard skills or did he subconsciously sabotage himself? These are the questions up for exploration in this penultimate episode of the series.

imageedit_13_7890990197

Continue reading “Billions ep 11 : Magical Thinking”

The Many Faces of Damian Lewis: Part 2

Sometimes an actor will find themselves type-cast, and the reasons for this can vary greatly. It can be the fault of a narrow-minded industry, a lazy agent, an iconic role that they find impossible to be divorced from, or simply from the actor’s own lack of range.

damian173
We are all lucky to be fans of a man who has not experienced this. Damian has had the pleasure of embodying many different types of men. And while so many of these characters have some sort of overlap(just how many times has he put on a military uniform now??), he has used his incredible skill set to create a different, iconic character in each role. Specifically, I want to talk about how he uses his body language to create believable characters that resonate. Continue reading “The Many Faces of Damian Lewis: Part 2”

Billions on Showtime, Episode 11: Magical Thinking

source: Showtime
source: Showtime

Well, night is young and magical for some and not so much for others in Billions Episode 11 Magical Thinking. 

Mafee sends in Wags to ask for permission to talk to Axe about BioLance that will make a special announcement in nine minutes about whether the FDA is giving approval for their diabetes type II drug. All the research points to the approval being a coin flip and Mafee, who usually sleeps like a bear, is losing sleep on it. He can pare their position right now just before the announcement and they can still make 10%. But they will lose 400 million should the FDA deny approval. Axe is not having any of it. 10% could be good for a benchmark fund which Axe Capital is NOT. They are already in BioLance where the win is. He fires Mafee on the spot. Continue reading “Billions on Showtime, Episode 11: Magical Thinking”